CoChat

Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations

Open access
Lorenz, Susanne, Barøy, Tale, Sun, Jinchang, Nome, Torfinn, Vodák, Daniel, Bryne, Jan-Christian, Håkelien, Anne-Mari, Fernandez-Cuesta, Lynnette, Möhlendick, Birte, Rieder, Harald, Szuhai, Karoly, Zaikova, Olga, Ahlquist, Terje C., Thomassen, Gard O. S., Skotheim, Rolf I., Lothe, Ragnhild A., Tarpey, Patrick S., Campbell, Peter, Flanagan, Adrienne, Myklebost, Ola, Meza-Zepeda, Leonardo A. · 2016 · Oncotarget
Cited by 88

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

// Susanne Lorenz 1,5 , Tale Barøy 1,14 , Jinchang Sun 2,5 , Torfinn Nome 3,10 , Daniel Vodák 1 , Jan-Christian Bryne 1,2 , Anne-Mari Håkelien 1 , Lynnette Fernandez-Cuesta 6,7 , Birte Möhlendick 8 , Harald Rieder 8 , Karoly Szuhai 9 , Olga Zaikova 4 , Terje C. Ahlquist 3,10 , Gard O. S. Thomassen 3,10 , Rolf I. Skotheim 3,10 , Ragnhild A. Lothe 3,10 , Patrick S. Tarpey 11 , Peter Campbell 11 , Adrienne Flanagan 12,13 , Ola Myklebost 1,5,* and Leonardo A. Meza-Zepeda 1,2,5,* 1 Department of Tumor Biology, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway 2 Genomics Core Facility, Department of Core Facilities, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway 3 Department of Molecular Oncology, Institute for Cancer research, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway 4 Clinic for Cancer, Surgery and Transplantation, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway 5 Norwegian Cancer Genomics Consortium, Norway 6 Department of Translational Genomics, Center of Integrated Oncology Cologne–Bonn, University of Cologne, Cologne, Germany 7 Genetic Cancer Susceptibility Group, International Agency for Research on Cancer (IARC-WHO), Lyon, France 8 Institute for Human Genetics, University Hospital Düsseldorf, Düsseldorf, Germany 9 Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands 10 Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway 11 Wellcome Trust Sanger Institute, Hinxton, UK 12 Royal National Orthopaedic Hospital, Middlesex, UK 13 UCL Cancer Institute, University College London, London, UK 14 Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway * These authors shared last authorship Correspondence to: Leonardo A. Meza-Zepeda, email: // Keywords : bone cancer, osteosarcomas, gene fusion, trans-splicing, DNA repair Received : July 16, 2015 Accepted : November 15, 2015 Published : December 11, 2015 Abstract In contrast to many other sarcoma subtypes, the chaotic karyotypes of osteosarcoma have precluded the identification of pathognomonic translocations. We here report hundreds of genomic rearrangements in osteosarcoma cell lines, showing clear characteristics of microhomology-mediated break-induced replication (MMBIR) and end-joining repair (MMEJ) mechanisms. However, at RNA level, the majority of the fused transcripts did not correspond to genomic rearrangements, suggesting the involvement of trans-splicing, which was further supported by typical trans-splicing characteristics. By combining genomic and transcriptomic analysis, certain recurrent rearrangements were identified and further validated in patient biopsies, including a PMP22-ELOVL5 gene fusion, genomic structural variations affecting RB1, MTAP/CDKN2A and MDM2 , and, most frequently, rearrangements involving TP53. Most cell lines (7/11) and a large fraction of tumor samples (10/25) showed TP53 rearrangements, in addition to somatic point mutations (6 patient samples, 1 cell line) and MDM2 amplifications (2 patient samples, 2 cell lines). The resulting inactivation of p53 was demonstrated by a deficiency of the radiation-induced DNA damage response. Thus, TP53 rearrangements are the major mechanism of p53 inactivation in osteosarcoma. Together with active MMBIR and MMEJ, this inactivation probably contributes to the exceptional chromosomal instability in these tumors. Although rampant rearrangements appear to be a phenotype of osteosarcomas, we demonstrate that among the huge number of probable passenger rearrangements, specific recurrent, possibly oncogenic, events are present. For the first time the genomic chaos of osteosarcoma is characterized so thoroughly and delivered new insights in mechanisms involved in osteosarcoma development and may contribute to new diagnostic and therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.6567

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 88

Metadata

Authors
Lorenz, S., Barøy, T., Sun, J., Nome, T., Vodák, D., Bryne, J.-C., Håkelien, A.-M., Fernandez-Cuesta, L., Möhlendick, B., Rieder, H., Szuhai, K., Zaikova, O., Ahlquist, T. C., Thomassen, G. O. S., Skotheim, R. I., Lothe, R. A., Tarpey, P. S., Campbell, P., Flanagan, A., Myklebost, O., & Meza-Zepeda, L. A.
Venue
Oncotarget
Published
2015-12-11
Volume
7
Issue
5
Pages
5273-5288
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2213752852
Cited by
88
References
13
FWCI
4.76
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations. https://app.cochat.ai/papers/10.18632/oncotarget.6567
The paper
Lorenz, S., Barøy, T., Sun, J., Nome, T., Vodák, D., Bryne, J.-C., Håkelien, A.-M., Fernandez-Cuesta, L., Möhlendick, B., Rieder, H., Szuhai, K., Zaikova, O., Ahlquist, T. C., Thomassen, G. O. S., Skotheim, R. I., Lothe, R. A., Tarpey, P. S., Campbell, P., Flanagan, A., . . . Meza-Zepeda, L. A. (2016). Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations. Oncotarget. https://doi.org/10.18632/oncotarget.6567

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.